with best-in-class real-world evidence
Innovation in behavioral health has long been hindered by a lack of standardization, including few universal measurements, a reliance on subjectivity, and limited evidence.
At Holmusk we build real-world data and analytics solutions to create a single source of truth for behavioral health. Our solutions help our partners generate evidence to enable successful treatment development, enhanced care delivery, and improved patient outcomes.
We’re ready to set the standard for behavioral health.
GET STARTED
We curate real-world data to enable better evidence—because we can’t improve patient outcomes until we first understand how care is actually delivered.
For clinical research
Gain actionable insights from a powerful evidence engine fueled by the behavioral health field’s most robust clinical database containing de-identified electronic health records from patients across the U.S.
LEARN MORE
For clinical care
Enhance care management with a clinical insights solution that visualizes electronic health record data and identifies high-risk cases—ensuring patients get the right care at the right time.
LEARN MORE
A peer-reviewed manuscript in Current Medical Research and Opinion uses NeuroBlu to healthcare utilization rates for patients with schizophrenia and bipolar disorder.
Read More
Catch up on the latest company announcements, including news about novel collaborations, innovative projects, awards, and more.
Read More
Curious about the latest developments in real-world evidence and mental health? Check out our blog, the Hol Picture, where leaders from across Holmusk share thoughts.
Read More
•Substance use disorders: 255k+ patients
•Major depressive disorder: 251k+ patients
•Bipolar disorder: 134k+ patients
•Attention-deficit/hyperactivity disorder: 82k+ patients
•Post-traumatic stress disorder: 63k+ patients
•Schizoaffective disorder: 34k+ patients
•Schizophrenia: 33k+ patients
•Borderline personality disorder: 19k+ patients
•Autism spectrum disorder: 16k+ patients
•Substance use disorders: 255k+ patients
•Major depressive disorder: 251k+ patients
•Bipolar disorder: 134k+ patients
•Attention-deficit/hyperactivity disorder: 82k+ patients
•Post-traumatic stress disorder: 63k+ patients
•Schizoaffective disorder: 34k+ patients
•Schizophrenia: 33k+ patients
•Borderline personality disorder: 19k+ patients
•Autism spectrum disorder: 16k+ patients
•Substance use disorders: 255k+ patients
•Major depressive disorder: 251k+ patients
•Bipolar disorder: 134k+ patients
•Attention-deficit/hyperactivity disorder: 82k+ patients
•Post-traumatic stress disorder: 63k+ patients
•Schizoaffective disorder: 34k+ patients
•Schizophrenia: 33k+ patients
•Borderline personality disorder: 19k+ patients
•Autism spectrum disorder: 16k+ patients
EXPLORE ALL PUBLICATIONS
•Substance use disorders: 255k+ patients
•Major depressive disorder: 251k+ patients
•Bipolar disorder: 134k+ patients
•Attention-deficit/hyperactivity disorder: 82k+ patients
•Post-traumatic stress disorder: 63k+ patients
•Schizoaffective disorder: 34k+ patients
•Schizophrenia: 33k+ patients
•Borderline personality disorder: 19k+ patients
•Autism spectrum disorder: 16k+ patients
•Substance use disorders: 255k+ patients
•Major depressive disorder: 251k+ patients
•Bipolar disorder: 134k+ patients
•Attention-deficit/hyperactivity disorder: 82k+ patients
•Post-traumatic stress disorder: 63k+ patients
•Schizoaffective disorder: 34k+ patients
•Schizophrenia: 33k+ patients
•Borderline personality disorder: 19k+ patients
•Autism spectrum disorder: 16k+ patients
•Substance use disorders: 255k+ patients
•Major depressive disorder: 251k+ patients
•Bipolar disorder: 134k+ patients
•Attention-deficit/hyperactivity disorder: 82k+ patients
•Post-traumatic stress disorder: 63k+ patients
•Schizoaffective disorder: 34k+ patients
•Schizophrenia: 33k+ patients
•Borderline personality disorder: 19k+ patients
•Autism spectrum disorder: 16k+ patients
Our real-world data solutions are leveraged by a wide range of stakeholders who share our vision that better evidence can transform research and care for behavioral health.
EXPLORE
patients
geographically-diverse health systems
years of longitudinal data
Follow patients over time with over 20 years of data, spanning inpatient and outpatient sites, including hospitals, emergency rooms, and community psychiatry clinics.
Conduct observational studies with data that are curated and ready to address your most challenging research questions.
Track patient functioning and outcomes and compare different groups of patients with standardized quantitative outcome measures.
We’d love for you to come along on the journey of improving behavioral health with better evidence.
Curious about what’s happening in the real-world evidence space? Check out our blog, the Hol Picture, where we share takeaways from recent talks and weigh in on news involving real-world evidence and behavioral health.
Explore recent peer-reviewed publications and conference abstracts that leveraged NeuroBlu data to share new real-world evidence with the scientific community.
Read More
Catch up on the latest company announcements, including news about novel collaborations, innovative projects, awards, and more.
Read More
Curious about the latest developments in real-world evidence and mental health? Check out our blog, the Hol Picture, where leaders from across Holmusk share thoughts.
Read More
We’re making fast strides toward a reimagined future for behavioral health, and we’d love for you to come along on our journey.